Genetic Signatures Limited (GSS.AX)
AUD 0.63
(-8.03%)
AUD 0.63
(-8.03%)
| Breakdown | 2024 | 2023 | 2022 | 2021 | 2020 | 2019 |
|---|---|---|---|---|---|---|
| Operating Cash Flow | -10.12 Million | -12.45 Million | 9.8 Million | 4.19 Million | -9.49 Million | -2.26 Million |
| Net Income | -17.86 Million | -14.05 Million | 3.06 Million | 1.75 Million | -2.08 Million | -3.49 Million |
| Depreciation & Amortization | 1.99 Million | 1.52 Million | 1.61 Million | 1.42 Million | 883 Thousand | 471 Thousand |
| Deferred income taxes | - | -7.41 Million | -1.66 Million | -8.79 Million | -11.28 Million | -152 Thousand |
| Stock-based compensation | - | 1.97 Million | 1.91 Million | 1.48 Million | 572 Thousand | 425 Thousand |
| Change in working capital | 4.11 Million | -2.18 Million | 3.68 Million | -1.62 Million | -8.44 Million | -273 Thousand |
| Other non-cash items | 1.37 Million | 7.7 Million | 1.19 Million | 9.95 Million | 10.85 Million | 752 Thousand |
| Investing Cash Flow | -4.79 Million | -8.09 Million | -2.98 Million | -4.97 Million | -2.35 Million | -610 Thousand |
| Investments in PPE | -4.79 Million | -8.09 Million | -2.98 Million | -4.97 Million | -2.35 Million | -610 Thousand |
| Acquisitions | - | - | - | - | - | - |
| Investment purchases | - | - | - | - | - | - |
| Sales/Maturities of investments | - | - | - | - | - | - |
| Other Investing Activities | -2.81 Million | -6.16 Million | -1.27 Million | -326 Thousand | -75 Thousand | - |
| Financing Cash Flow | 34.81 Million | -23 Thousand | -101 Thousand | -190 Thousand | 36.68 Million | 250 Thousand |
| Debt repayment | - | -33 Thousand | -365 Thousand | -341 Thousand | -299 Thousand | - |
| Dividends payments | - | - | - | - | - | - |
| Common Stock Repurchased | -2.53 Million | -1000.00 | -9000.00 | -12 Thousand | -1.89 Million | -5652.00 |
| Common Stock Issuance | 37.52 Million | 10 Thousand | 264 Thousand | 151 Thousand | 36.98 Million | 250.19 Thousand |
| Other Financing Activities | -177 Thousand | 25 Thousand | 119 Thousand | 214 Thousand | 36.68 Million | 5455.00 |
| Accounts receivables | 2.71 Million | -3.92 Million | 1.24 Million | -293 Thousand | -4.36 Million | -100 Thousand |
| Accounts payables | -83 Thousand | 506 Thousand | 313 Thousand | 984 Thousand | 1.31 Million | 277.36 Thousand |
| Inventory | 1.61 Million | 1.02 Million | 1.93 Million | -5.15 Million | -5.89 Million | -173 Thousand |
| Other working capital | -127 Thousand | 207 Thousand | 198 Thousand | 2.83 Million | 501 Thousand | -277.36 Thousand |
| Cash at beginning of period | 16.34 Million | 36.89 Million | 30.12 Million | 31.17 Million | 6.31 Million | 8.95 Million |
| Cash at end of period | 36.25 Million | 16.34 Million | 36.89 Million | 30.12 Million | 31.17 Million | 6.31 Million |
| Capital Expenditure | -4.79 Million | -8.09 Million | -2.98 Million | -4.97 Million | -2.35 Million | -610 Thousand |
| Effect of forex changes on cash | -1000.00 | 20 Thousand | 60 Thousand | -81 Thousand | 22 Thousand | -14 Thousand |
| Net cash flow / Change in cash | 19.9 Million | -20.54 Million | 6.77 Million | -1.05 Million | 24.86 Million | -2.64 Million |
| Free Cash Flow | -14.91 Million | -20.54 Million | 6.81 Million | -784 Thousand | -11.84 Million | -2.87 Million |
| Breakdown | 2024 Q4 | 2024 FY | 2024 Q2 | 2023 Q4 | 2023 FY | 2023 Q2 |
|---|---|---|---|---|---|---|
| Operating Cash Flow | - | - | - | - | - | - |
| Net Income | -7.39 Million | -17.86 Million | -10.46 Million | -7.57 Million | -14.05 Million | -6.48 Million |
| Depreciation & Amortization | 1.21 Million | 1.99 Million | 781 Thousand | 824 Thousand | 1.52 Million | 702 Thousand |
| Deferred income taxes | - | - | - | -5.14 Million | -7.41 Million | - |
| Stock-based compensation | - | - | - | 1.97 Million | 1.97 Million | - |
| Change in working capital | - | 4.11 Million | - | -2.69 Million | -2.18 Million | - |
| Other non-cash items | 946 Thousand | 1.37 Million | 8.79 Million | 1.25 Million | 7.7 Million | 1.87 Million |
| Investing Cash Flow | -1.55 Million | -4.79 Million | -3.24 Million | -3.36 Million | -8.09 Million | -4.72 Million |
| Investments in PPE | -1.55 Million | -4.79 Million | -3.24 Million | -3.36 Million | -8.09 Million | -4.72 Million |
| Acquisitions | - | - | - | - | - | - |
| Investment purchases | - | - | - | - | - | - |
| Sales/Maturities of investments | - | - | - | - | - | - |
| Other Investing Activities | - | - | -2.44 Million | -3.2 Million | -6.16 Million | -2.95 Million |
| Financing Cash Flow | 27.33 Million | 34.81 Million | 7.47 Million | -1000.00 | -23 Thousand | -22 Thousand |
| Debt repayment | - | - | - | - | -33 Thousand | -32 Thousand |
| Dividends payments | - | - | - | - | - | - |
| Common Stock Repurchased | - | - | - | - | -1000.00 | - |
| Common Stock Issuance | 27.51 Million | 34.99 Million | 7.47 Million | - | 10 Thousand | 10 Thousand |
| Other Financing Activities | -177 Thousand | - | 7.47 Million | -1000.00 | 25 Thousand | 10 Thousand |
| Accounts receivables | - | 2.71 Million | - | 496 Thousand | -3.92 Million | - |
| Accounts payables | - | -83 Thousand | - | - | 506 Thousand | - |
| Inventory | - | 1.61 Million | - | 1.02 Million | 1.02 Million | - |
| Other working capital | - | -127 Thousand | - | -4.21 Million | 207 Thousand | - |
| Cash at beginning of period | 18.12 Million | 16.34 Million | 16.34 Million | 26.84 Million | 36.89 Million | 36.89 Million |
| Cash at end of period | 36.25 Million | 36.25 Million | 18.12 Million | 16.34 Million | 16.34 Million | 26.84 Million |
| Capital Expenditure | -1.55 Million | -4.79 Million | -3.24 Million | -3.36 Million | -8.09 Million | -4.72 Million |
| Effect of forex changes on cash | - | - | -5000.00 | 12 Thousand | 20 Thousand | 8000.00 |
| Net cash flow / Change in cash | 18.12 Million | 19.9 Million | 1.77 Million | -10.5 Million | -20.54 Million | -10.04 Million |
| Free Cash Flow | -9.21 Million | -14.91 Million | -5.69 Million | -10.51 Million | -20.54 Million | -10.03 Million |
1733
300600
603345
HSTA
FPAY
SNT